A clinical evaluation program to monitor neurocognitive risk in children and adolescents with sickle cell disease-Reference-Cited by-同舟云学术

A clinical evaluation program to monitor neurocognitive risk in children and adolescents with sickle cell disease

Published:2024-09-04 Issue: Volume: Page:1-21
ISSN:1385-4046
Container-title:The Clinical Neuropsychologist
language:en
Short-container-title:The Clinical Neuropsychologist

Author:

Longoria Jennifer N.¹^ORCID,Schreiber Jane E.²,Potter Brian¹,Raches Darcy¹,MacArthur Erin¹,Cohen Diana³,Brazley-Rodgers Marshetta⁴,Hankins Jane S.⁵^ORCID,Heitzer Andrew M.¹^ORCID

Affiliation:

1. Department of Psychology and Biobehavioral Sciences, St. Jude Children’s Research Hospital, Memphis, TN, USA

2. Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

3. Department of Psychology and Neuropsychology, Children’s Hospital of Orange County, Orange, CA, USA

4. School Program and Liaison Services, St. Jude Children’s Research Hospital, Memphis, TN, USA

5. Global Pediatric Medicine and Hematology, St. Jude Children’s Research Hospital, Memphis, TN, USA

Funder

Global Blood Therapeutics

National Heart, Lung, and Blood Institute

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13854046.2024.2399861

Reference46 articles.

1. Lessons From the Stroke Prevention Trial in Sickle Cell Anemia (STOP) Study

2. Implementing guidelines: Proposed definitions of neuropsychology services in pediatric oncology

3. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort

4. Centers for Disease Control and Prevention. (2022). Data and statistics of sickle cell disease. https://www.cdc.gov/ncbddd/sicklecell/data.html

5. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia